Search Within

Center for Pancreatic Cancer Research

Formats
  1. Journal Article (5064)
  2. Meeting Abstract (2483)
  3. Book Section (225)
  4. Review (221)
  5. Editorial (135)
  6. Conference Paper (75)
  7. Correspondence (48)
  8. Research Letter (43)
  9. Miscellaneous (41)
  10. Guidelines (38)
  11. Book Whole (20)
Groups
  1. Department of Medicine (3946)
  2. Solid Tumor Oncology Division (3243)
  3. Surgery (3170)
  4. GSK Faculty (2916)
  5. Epidemiology and Biostatistics (2527)
  6. Gastrointestinal Oncology Service (2298)

More Groups

People
  1. Mithat Gonen (1036)
  2. William Jarnagin (913)
  3. Eileen O'Reilly (795)
  4. Michael D'Angelica (789)
  5. T Peter Kingham (622)
  6. David Kelsen (538)

More People

Years
  1. 2025 (294)
  2. 2024 (497)
  3. 2023 (523)
  4. 2022 (602)
  5. 2021 (555)
  6. 2020 (562)

More Years

Publications
  1. Journal of Clinical Oncology (927)
  2. Annals of Surgical Oncology (397)
  3. Cancer Research (226)
  4. International Journal of Radiation Oncology, Biology, Physics (219)
  5. Laboratory Investigation (209)
  6. Modern Pathology (191)

More Publications

Publishers
  1. American Society of Clinical Oncology (1003)
  2. Springer (842)
  3. Elsevier Inc. (757)
  4. Nature Publishing Group (633)
  5. American Association for Cancer Research (551)
  6. Elsevier Science, Inc. (510)

More Publishers

Results (8393)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Contemporary reappraisal of intraoperative neck margin assessment during pancreaticoduodenectomy for pancreatic ductal adenocarcinoma: A review
    Review

    Datta, J.; Willobee, B. A.; Ryon, E. L.; Shah, M. M.; Drebin, J. A.; Kooby, D. A.; Merchant, N. B.
    JAMA Surgery (2021)

    Fulltext@MSK | Save
  • Cytotoxic lymphocytes target characteristic biophysical vulnerabilities in cancer
    Journal Article

    Tello-Lafoz, M.; Srpan, K.; Sanchez, E. E.; Hu, J.; Remsik, J.; Romin, Y.; Calò, A.; Hoen, D.; Bhanot, U.; Morris, L.; more...
    Immunity (2021)

    Fulltext@MSK | Save
  • Any day, split halfway: Flexibility in scheduling high-dose cisplatin - A large retrospective review from a high-volume cancer center
    Journal Article

    Kang, J. J.; Tchekmedyian, V.; Mohammed, N.; Rybkin, A.; Kitpanit, S.; Fan, M.; Wang, H.; Lobaugh, S. M.; Zhang, Z.; Lee, A.; more...
    International Journal of Cancer (2021)

    Fulltext@MSK | Save
  • Melanoma models for the next generation of therapies
    Review

    Patton, E. E.; Mueller, K. L.; Adams, D. J.; Anandasabapathy, N.; Aplin, A. E.; Bertolotto, C.; Bosenberg, M.; Ceol, C. J.; Burd, C. E.; Chi, P.; more...
    Cancer Cell (2021)

    Fulltext@MSK | Save
  • Decreased public pursuit of cancer-related information during the COVID-19 pandemic in the United States
    Journal Article

    Adelhoefer, S.; Berning, P.; Solomon, S. B.; Maybody, M.; Whelton, S. P.; Blaha, M. J.; Dzaye, O.
    Cancer Causes & Control (2021)

    Fulltext@MSK | Save
  • Geospatial access predicts cancer stage at presentation and outcomes for patients with breast cancer in southwest Nigeria: A population-based study
    Journal Article

    Knapp, G. C.; Tansley, G.; Olasehinde, O.; Wuraola, F.; Adisa, A.; Arowolo, O.; Olawole, M. O.; Romanoff, A. M.; Quan, M. L.; Bouchard-Fortier, A.; more...
    Cancer (2021)

    Fulltext@MSK | Save
  • Prognostic value of the Memorial Sloan Kettering Prognostic Score in metastatic pancreatic adenocarcinoma
    Journal Article

    Lebenthal, J. M.; Zheng, J.; Glare, P. A.; O’Reilly, E. M.; Yang, A. C.; Epstein, A. S.
    Cancer (2021)

    Fulltext@MSK | Save
  • Preoperative CT predictors of survival in patients with pancreatic ductal adenocarcinoma undergoing curative intent surgery
    Journal Article

    Dickinson, S. M.; McIntyre, C. A.; Schilsky, J. B.; Harrington, K. A.; Gerst, S. R.; Flynn, J. R.; Gonen, M.; Capanu, M.; Wong, W.; Lawrence, S.; more...
    Abdominal Radiology (2021)

    Fulltext@MSK | Save
  • Health-related quality of life in patients with microsatellite instability-high or mismatch repair deficient metastatic colorectal cancer treated with first-line pembrolizumab versus chemotherapy (KEYNOTE-177): An open-label, randomised, phase 3 trial
    Journal Article

    Andre, T.; Amonkar, M.; Norquist, J. M.; Shiu, K. K.; Kim, T. W.; Jensen, B. V.; Jensen, L. H.; Punt, C. J. A.; Smith, D.; Garcia-Carbonero, R.; more...
    Lancet Oncology (2021)

    Fulltext@MSK | Save
  • Inferences about drug safety in phase III trials in oncology: Examples from advanced prostate cancer
    Journal Article

    Drago, J. Z.; Gönen, M.; Thanarajasingam, G.; Sacks, C. A.; Morris, M. J.; Kantoff, P. W.; Stopsack, K. H.
    JNCI: Journal of the National Cancer Institute (2021)

    Fulltext@MSK | Save